FDA OKs Lusutrombopag for Thrombocytopenia in Liver Disease FDA OKs Lusutrombopag for Thrombocytopenia in Liver Disease

The thrombopoietin receptor agonist is for adults with chronic liver disease who are scheduled to undergo a medical or dental procedure.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news